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Abstract
Aims/hypothesis Homozygous staggerer (sg/sg)m i c e ,w h i c h
have decreased and dysfunctional Rorα (alsoknownasRora)
expression in all tissues, display a lean and dyslipidaemic
phenotype. They are also resistant to (high fat) diet-induced
obesity. We explored whether retinoic acid receptor-related
orphan receptor (ROR) α action in skeletal muscle was
involved in the regulation of glucose metabolism.
Methods Weusedathree-armedgenomicapproach,including
expression profiling, ingenuity analysis and quantitative PCR
validation to identify the signalling pathway(s) in skeletal
muscle that are perturbed in sg/sg mice. Moreover, western
analysis, functional insulin and glucose tolerance tests, and
ex vivo glucose uptake assays were used to phenotypically
characterise the impact of aberrant v-AKT murine thymoma
viral oncogene homologue (AKT) signalling.
Results Homozygous and heterozygous (sg/sg and sg/+)
animals exhibited decreased fasting blood glucose levels,
mildly improved glucose tolerance and increased insulin
sensitivity. Illumina expression profiling and bioinformatic
analysis indicated the involvement of RORα in metabolic
disease and phosphatidylinositol 3-kinase–AKT signalling.
Quantitative PCR and western analysis validated increased
AKT2 (mRNA and protein) and phosphorylation in sg/sg
mice in the basal state. This was associated with increased
expression of Tbc1d1 and Glut4 (also known as Slc2a4)
mRNA and protein. Finally, in agreement with the pheno-
type, we observed increased (absolute) levels of AKT and
phosphorylated AKT (in the basal and insulin stimulated
states), and of (ex vivo) glucose uptake in skeletal muscle
from sg/sg mice relative to wild-type littermates.
Conclusions/interpretation We propose that Rorα plays an
important role in regulation of the AKT2 signalling
cascade, which controls glucose uptake in skeletal muscle.
Keywords AKT.Glucose tolerance.Metabolism.Nuclear
hormone receptor.Retinoic acid receptor-related orphan
receptor alpha
Abbreviations
AKT v-AKT murine thymoma viral oncogene
homologue
EDL Extensor digitorum longus
GAPDH Glyceraldehyde-3-phosphate dehydrogenase
NR Nuclear hormone receptor
pAKT Phosphorylated AKT
PI3K Phosphatidylinositol 3-kinase
RER Respiratory exchange ratio
ROR Retinoic acid receptor-related orphan receptor
ser473 Serine amino acid residue 473
TBC1D1 TBC1 domain family, member 1
Introduction
Retinoic acid receptor-related orphan receptor (ROR) alpha
is a member of the nuclear hormone receptor (NR)
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binding factors that translate hormonal, nutritional and
pathophysiological signals into gene regulation. In the
context of metabolism, NRs control lipid and glucose
homeostasis in an organ- or tissue-specific manner [1–4]. It
has been demonstrated that liver x receptor agonists and
oxygenated sterols function as RORα/γ ligands that can
suppress receptor activity [5].
Several studies on RORα [2–4, 6, 7] have revealed a
role for this NR in fatty acid homeostasis [8]. Homozygous
staggerer (sg/sg) mice, which have a global Rorα (also
known as Rora) defect, display decreased and dysfunctional
RORα (1 and 4) levels in all tissues [7, 9–11]. Moreover,
sg/sg mice have a lean and dyslipidaemic phenotype, and
are similar to Rorα-deficient mice (sg operates as a non-
functional null allele) [12]. These mice display hypoalpha-
lipoproteinaemia, decreased serum triacylglycerol and HDL-
cholesterol [3], vulnerability to atherosclerosis [3], decreased
fat depots and resistance to diet-induced obesity [9].
Dysfunctional NR signalling has been associated with
dyslipidaemia, insulin resistance, diabetes and obesity [6,
7]. For example, the dietary lipid-dependent NRs (peroxi-
some proliferator-activated receptor-gamma, liver x recep-
tor alpha etc.) in skeletal muscle regulate insulin-stimulated
glucose disposal, and lipid and energy homeostasis [13–
15]. Muscle is a major mass tissue that accounts for around
40% of the total body mass and energy expenditure, and is
a major site of glucose disposal. Hence muscle has an
important role in regulating insulin sensitivity and is
increasingly recognised as an important target for combat-
ing type 2 diabetes.
Type 2 diabetes is a complex metabolic disease
characterised by glucose intolerance and insulin resistance,
which result in decreased insulin-mediated glucose utilisa-
tion in peripheral tissues [16]. In this context, investigation
of the role of the orphan NR, RORα, in the regulation of
glucose metabolism has not been completely analysed in
the literature. Accordingly, we surveyed the functional role
of RORα in glucose tolerance and insulin sensitivity, with
particular attention to skeletal muscle.
We observed that homozygous (sg/sg) and heterozygous
(sg/+) mice exhibited mildly improved glucose tolerance
and increased insulin sensitivity. Expression profiling
identified perturbations in the v-AKT murine thymoma
viral oncogene homologue (AKT) signalling cascade and in
genes involved in the control of glucose homeostasis. For
example, we observed enhanced (absolute) levels of: (1)
Akt2 mRNA in the basal state; and (2) phosphorylated AKT
(pAKT) (in the basal and insulin stimulated states); and (3)
(ex vivo) glucose uptake in skeletal muscle from sg/sg mice
relative to wild-type littermates. In summary, RORα plays
an important role in regulation of the AKT signalling
cascade.
Methods
Animals Heterozygous sg/+ mice, B6.C3(Cg)-Rora
sg/J,
were obtained from Jackson laboratory (Bar Harbor, ME,
USA) and maintained by backcrossing to C57BL/6 J.
Feeding has been described previously [9]. Male wild-
type and homozygous (sg/sg) mice were fed with a normal
diet until 14 weeks and fasted for 6 h by transferring to a
food-free holding cage with access to water. Animals were
killed and tissues collected and immediately frozen in
liquid nitrogen. All animal procedures were approved by
The University of Queensland Animal Ethics Committee.
Glucose tolerance test Blood glucose measurements were
obtained from the tail vein of 12 h fasted animals (14–
16 weeks old) following glucose challenge, using a blood
glucose testing system (Accu-chek Performa; Roche Diag-
nostics, Castle Hill, NSW, Australia) [17].
Insulin tolerance test and insulin stimulation of AKT
phosphorylation Blood glucose measurements were
obtained from 6 h fasted animals (14–16 weeks old)
following insulin challenge, as previously described [17].
For measurement of skeletal muscle pAKT, 6 h fasted mice
were administered insulin or saline as described for insulin
tolerance test, killed by CO2 asphyxiation after 10 min and
quadriceps muscle excised and snap-frozen.
Microarray analysis Microarray and statistical analysis
were as previously described [17] except that GeneSpring
GX v7.3.1 (Agilent, Santa Clara, CA, USA) was used for
analysis.
RNA extraction, cDNA synthesis and quantitative PCR
Total RNA extraction, cDNA synthesis and quantitative
PCR were performed as previously described [2, 9].
Primers are listed in the Electronic supplementary material
(ESM) Table 1.
Protein extraction and western blot analysis Protein ex-
traction and western analysis was performed as previously
described [17] with the following modifications. The lysis
buffer contained 50 mmol/l Tris (pH 8.0), 150 mmol/l NaCl,
1% (vol./vol.) Triton X-100, 1% (wt/vol.) NP40 and 0.1%
(wt/vol.) SDS, and tissue was centrifuged at 2,000×g.
Membranes were blocked with either 5% (wt/vol.) dried
skimmed milk or 5% (wt/vol.) BSA (for phospho-specific
antibodies). The anti-GLUT4 (number 62375; Abcam,
Cambridge, MA, USA) antibody was used at 1:5,000.
2-Deoxy-D-glucose uptake assay Extensor digitorum lon-
gus (EDL) muscles were dissected from mice (3–7 months
old) following cervical dislocation and 2-deoxy-D-glucose
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stimulation (Actrapid; Nova Nordisk, Baulkham Hills, NSW,
Australia) as previously described [18, 19].
Indirect calorimetry Respiratory exchange ratio (RER) was
measured using a monitoring system (Oxymax Compre-
hensive Lab Animal System; Columbus Instruments,
Columbus, OH, USA). Mice were housed individually in
metabolic cages on a 12 hday–night cycle. Following an
initial 14 h acclimatisation period, measurements were
taken every 10 min for 24 h on normal diet (D12450B;
Research Diets, New Brunswick, NJ, USA). After 24 h
measurement, food was then withdrawn and measurements
were taken for a further 6 h.
Statistical analysis Results were analysed by unpaired t test
or one-way ANOVA with Bonferroni’s post-hoc test, or by
two-way ANOVA with Bonferroni’s post hoc test; Prism 5
software (GraphPad, San Diego, CA, USA) was used.
Results
Staggerer mice present decreased fasting glucose levels,
improved glucose tolerance and increased insulin sensitivity
We have previously demonstrated that homozygous staggerer
(sg/sg) mice (with decreased and dysfunctional RORα
levels) display a lean phenotype. Here, we used sg/sg mice
to elucidate the role of RORα in glucose tolerance and
insulin sensitivity. We examined male wild-type and homo-
zygous sg/sg mice fed a normal diet until 14 weeks and
observed significantly lower blood glucose levels in homo-
zygous sg/sg than in wild-type mice (n=7–11) after 6 and
12 h of fasting (Fig. 1a, b). Plasma insulin levels in the sg/sg,
relative to wild-type mice were also decreased (but did not
attain significance, p=0.08) (Fig. 1c). We further examined
systemic glucose metabolism and performed intraperito-
neal glucose tolerance tests. In the sg/sg mice, glucose
clearance was mildly improved following a glucose
challenge (Fig. 1d, e), with no significant differences in
insulin secretion after 10 min (data not shown). The sg/sg
mice also displayed significantly enhanced responsiveness
to administration of intraperitoneal insulin, indicating
enhanced whole-body insulin action compared with wild-
type mice (Fig. 1f, g).
Homozygous sg/sg mice are characteristically lean. They
display decreased adipose mass and body weight [9]. In
contrast, the size:weight ratio of heterozygote (sg/+,
haploinsufficient) mice is comparable to that of their wild-
type counterparts (ESM Fig. 1a, b). The heterozygous sg/+
mice provided a tool to investigate whether the improve-
ment in insulin sensitivity observed in sg/sg mice involved
differential adiposity. Therefore we investigated whether
Fig. 1 a Starting blood glucose levels of 6 h fasted male homozygous
sg/sg (black column), heterozygous sg/+ (het) (striped column) and
wild-type (white column) mice. These mice were used for insulin
tolerance test (f, g); n=5–9 per group, mean±SEM; **p<0.01 by one-
way ANOVAwith Bonferroni’s post hoc test. b Starting blood glucose
levels of 12 h fasted mouse groups as above (a). These mice were
used for GTT (d, e); n=6–11 per group, mean±SEM; **p<0.01 by
one-way ANOVA with Bonferroni’s post hoc test. c Plasma insulin
concentrations of 12 h fasted male sg/sg wild-type littermate control
mice on a regular chow diet; n=4 per group, mean±SEM. d, e
Glucose tolerance tests. Blood glucose concentrations were measured
at various times (d) after i.p. administration of glucose (t=0) to 12 h
fasted male sg/sg (black squares), sg/+ (het) (circles) and wild-type
(Wt) (white squares) littermate control mice; n=6–11 per group, mean
±SEM; *p<0.05 by two-way ANOVAwith Bonferroni’s post hoc test.
e Mean AUC from glucose tolerance test; mean±SEM; *p<0.05 by
one-way ANOVA with Bonferroni’s post hoc test. f, g Insulin
tolerance tests. Blood glucose concentrations were measured and
expressed as percentage of starting glucose (t=0) at various times (f)
after i.p. administration of insulin (t=0) to 6 h fasted male sg/sg (black
squares), sg/+ (het) (circles) and wild-type littermate control (white
squares) mice; n=5–9 per group, mean±SEM; *p<0.05, **p<0.01
and ***p<0.001 by two-way ANOVAwith Bonferroni’s post hoc test.
g Mean AUC from insulin tolerance test; mean±SEM; *p<0.05, **p<
0.01 by one-way ANOVA with Bonferroni’s post-hoc test
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sg/+ mice. We observed significant improvement in glucose
tolerance and insulin sensitivity compared with wild-type
mice (Fig. 1d–g), indicating that the increased insulin
sensitivity was independent of the animal’s degree of
adiposity (and weight).
We also explored whether the improvement in insulin
sensitivity involved a shift to (more insulin-sensitive) type
I/slow fibres and/or oxidative type IIa/x fibres. According-
ly, we examined the four myosin heavy chain genes, Myh1,
-2, -4 and -7 (in wild-type and sg/sg mice), which identify
and classify types I, IIa, IIb and IIx fibres, respectively
(ESM Fig. 2a–d). In addition, we also examined mRNA
expression of the genes encoding type I and II troponin I's
(Tnni1, Tnni2) (ESM Fig. 2e, f). There were no significant
shifts in the mRNA expression of genes encoding any of
these fibre type markers. This suggests that improved
insulin sensitivity was independent of transitions in muscle
fibre types.
Whole-body metabolic analysis indicated that RER in
wild-type and sg/sg mice was similar (in the fed or dark,
and fasted phases), suggesting that these lines use fats and
carbohydrates for energy to a similar degree in the dark and
light phases (Fig. 2a, b). The sg/sg mice are characteristi-
cally lean [9] and resistant to diet-induced obesity [9]. We
also showed (ESM Fig. 1c, d) that on the regular chow diet
the wild-type and sg/sg littermates ate similar quantities of
food. O2 consumption in the sg/sg relative to wild-type mice
was significantly increased. These observations are consistent
with previous reports that demonstrated a 30 to 70% higher
metabolic rate (depending on temperature) and higher
endogenous levels of norepinephrine in (cold-reared) sg/sg
mice relative to control mice [20], and increased β2-AR (also
known as Adrb2) mRNA expression in brown adipose tissue
from sg/sg mice [9]. In summary, the sg/sg mice displayed
mildly improved glucose tolerance and increased insulin
sensitivity.
Expression profiling of skeletal muscle from sg/sg mice
identified differential expression of genes involved in AKT
signalling, and in cardiovascular and metabolic disease To
probe the mechanisms underlying improved insulin sensi-
tivity, we performed expression profiling analysis using
BeadArray chips (46 K; Illumina Sentrix; Illumina, San
Diego, CA, USA). Muscle (quadriceps) RNA from three
male sg/sg mice and their wild-type littermates was utilised
for analysis. Statistically significant differential up- and
downregulation of annotated genes was determined on the
basis of a p value cut-off of p<0.05 and a fold change cut-
off of 1.2 as shown in Tables 1 and 2, respectively (for the
complete list, see ESM Fig. 3a, b, c). All differentially
expressed genes were analysed using Ingenuity Pathway
Analysis (www.ingenuity.com) to examine their putative
function and associated signalling pathways.
The phosphatidylinositol 3-kinase (PI3K)–AKT signal-
ling pathway was the primary pathway to be upregulated
(ESM Fig. 4c)i nsg/sg mice. We focused on the PI3K–
AKT pathway to better understand the role of RORα (and
the effect of RORα deficiency) on skeletal muscle
carbohydrate metabolism. Importantly, using Ingenuity
Pathway Analysis, this pathway also had the highest
ranking association with genes that are significantly
upregulated in bead-array (Illumina) analysis. For example,
the PI3K–AKT pathway had the highest ratio (4.4×10
−2),
i.e. calculation of the number of genes in a pathway that
are differentially expressed (in a significant manner)
divided by the total number of known genes in that
pathway. Second, it displayed a very significant p value
(1.1×10
−4), i.e. confidence of the association between the
pathway and the differentially expressed genes.
This is consistent with a phenotype displaying improved
insulin sensitivity. The majority of differentially expressed
genes were associated with metabolic disease, diabetes,
dyslipidaemia and obesity (ESM Fig. 5).
Akt2 expression is increased in staggerer (sg/sg) mice The
Ingenuity analysis identified PI3K–AKT signalling as the
most significantly increased pathway. In the context of
further elucidating the mechanisms involved in the control
Fig. 2 CLAMS Oxymax metabolic monitoring of sg/sg (black circles
and columns) and wild-type littermate control (white circles and
columns) mice. a RER measurement over 12 h (day) and 12 h (night)
with food and 6 h fasting. b Mean±SEM for RER measurement in
specified phases (a). n=8–11 per group
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Gene symbol Gene name Genbank ID Fold change p value
Plekhh1 Pleckstrin homology domain containing, family H
(with Myth4 domain) member 1
XM_126961.4 1.97 0.002
Cidea Cell death-inducing DNA fragmentation factor, alpha
subunit-like effector a
NM_007702.1 1.69 0.039
Dnase1 Deoxyribonuclease 1 NM_010061.2 1.64 0.005
Ddit4 DNA-damage-inducible transcript 4 NM_029083.1 1.57 0.018
Synj2 Synaptojanin 2 AK038038 1.56 0.008
Tph1 Tryptophan hydroxylase 1 NM_009414.1 1.50 0.003
Cdkn1a Cyclin-dependent kinase inhibitor 1a (p21) NM_007669.2 1.49 0.026
Egln3 EGL nine homologue 3 AK033509 1.49 0.044
Gng2 Guanine nucleotide binding protein (G protein), gamma 2 subunit NM_010315.2 1.48 0.000
Klk1b26 Kallikrein 1-related petidase b26 NM_010644.2 1.44 0.012
Akt2 Thymoma viral proto-oncogene 2 NM_007434.2 1.44 0.036
Tns3 Tensin-3 NM_001083587 1.44 0.027
Mt2 Metallothionein 2 NM_008630.1 1.43 0.024
Igh-1a Immunoglobulin heavy chain 1a XM_354704.1 1.43 0.044
Bcl2 B cell leukaemia/lymphoma 2 NM_009741.2 1.43 0.016
Chrna9 Cholinergic receptor, nicotinic, alpha polypeptide 9 XM_132045.2 1.40 0.030
Snrk SNF related kinase NM_133741.1 1.40 0.050
Acot11 Acyl-CoA thioesterase 11 NM_025590.4 1.39 0.033
Slc25a25 Solute carrier family 25, member 25 NM_146118.2 1.39 0.040
Syt12 Synaptotagmin 12 NM_134164.2 1.38 0.009
Foxo1 Forkhead box o1 NM_019739.2 1.37 0.040
Cdkn1a Cyclin-dependent kinase inhibitor 1a (p21) NM_007669.2 1.36 0.035
Tsc22d1 TSC22 domain family, member 1 NM_009366.3 1.36 0.015
Tsc22d3 TSC22 domain family, member 3 NM_010286.2 1.36 0.013
Igfbp3 Insulin-like growth factor binding protein 3 NM_008343.1 1.35 0.015
Notch4 Notch gene homologue 4 (Drosophila) NM_010929.1 1.34 0.010
Car2 Carbonic anhydrase 2 NM_009801.3 1.34 0.005
Mt3 Metallothionein 3 NM_013603.1 1.32 0.002
Tbrg4 Transforming growth factor beta regulated gene 4 NM_134011.1 1.32 0.043
Tbc1d1 TBC1 domain family, member 1 NM_019636.1 1.31 0.004
Map3k6 Mitogen-activated protein kinase 6 NM_016693 1.31 0.046
Sox13 SRY-box containing gene 13 NM_011439.1 1.31 0.016
Shcbp1 Shc SH2-domain binding protein 1 NM_011369.1 1.30 0.033
Lmcd1 LIMand cysteine-rich domains 1 NM_144799.1 1.29 0.009
Syn2 Synapsin II NM_013681.1 1.29 0.017
Ercc5 Excision repair cross-complementing rodent repair deficiency,
complementation group 5
NM_011729.1 1.29 0.040
Syt3 Synaptotagmin 3 NM_016663.2 1.29 0.035
Car4 Carbonic anhydrase 4 NM_007607.1 1.28 0.003
Fgfr2 Fibroblast growth factor receptor 2, transcript variant 1 NM_010207.1 1.28 0.013
Dlk1 Delta-like 1 homologue (Drosophila) NM_010052.1 1.27 0.005
Itga10 Integrin, alpha 10 XM_112192 1.27 0.026
Klk1b26 Kallikrein 1-related petidase b26 NM_010644.2 1.26 0.013
Plin3 Perilipin 3 NM_025836.3 1.26 0.004
Prom1 Prominin 1 NM_008935.1 1.26 0.002
Zbtb32 Zinc finger and BTB domain containing 32 NM_021397.2 1.26 0.041
Sh3bp2 SH3-domain binding protein 2 NM_011893 1.26 0.012
Car14 Carbonic anhydrase 14 NM_011797.1 1.25 0.001
Olfr420 Olfactory receptor 420 NM_146305.1 1.25 0.033
Fkbp5 FK506 binding protein 5 NM_010220.2 1.25 0.029
Lao1 l-amino acid oxidase 1 NM_133892.3 1.25 0.017
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Gene symbol Gene name Genbank ID Fold
change
p value
Cpeb2 Cytoplasmic polyadenylation element binding protein 2 NM_175937 −1.79 0.007
Opn1mw Opsin 1 (cone pigments), medium-wave-sensitive (colour blindness, deutan) NM_008106.1 −1.70 0.026
Stab2 Stabilin 2 NM_138673.1 −1.69 0.000
Sfrp2 Secreted frizzled-related sequence protein 2 NM_009144.1 −1.65 0.025
Col7a1 Procollagen, type VII, alpha 1 NM_007738.1 −1.64 0.001
Pla2g7 Phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) NM_013737.2 −1.52 0.006
Hspa1a Heat shock protein 1a NM_010479 −1.50 0.034
Cadm1 Cell adhesion molecule 1, transcript variant 3 NM_018770.3 −1.50 0.011
Cadm1 Cell adhesion molecule 1, transcript variant 3 NM_018770.3 −1.50 0.026
Cldn10 Claudin 10, transcript variant 2 NM_021386 −1.47 0.011
Cited4 Cbp/P300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 NM_019563 −1.45 0.046
Pogk Pogo transposable element with KRAB domain NM_175170 −1.45 0.007
Tiam1 T cell lymphoma invasion and metastasis 1 NM_009384.1 −1.44 0.002
Ptx3 Pentaxin related gene NM_008987.2 −1.38 0.042
Phex Phosphate regulating gene with homologies to endopeptidases on the X chromosome NM_011077.1 −1.37 0.046
Ifitm6 Interferon induced transmembrane protein 6 XM_133956.3 −1.36 0.036
Gne Glucosamine NM_015828 −1.36 0.015
Fbn1 Fibrillin 1 AK080935 −1.34 0.020
Pon1 Paraoxonase 1 NM_011134.1 −1.34 0.020
Exph5 Exophilin 5 NM_176846.3 −1.34 0.021
Rasd2 RASD family, member 2 XM_204287.3 −1.33 0.005
Adamts1 A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin
type 1 motif, 1
NM_009621 −1.33 0.026
Timd4 T cell immunoglobulin and mucin domain containing 4 NM_178759.3 −1.33 0.032
Cd209d CD209 antigen-like protein d NM_130904.2 −1.33 0.027
Neto2 Neuropilin (NRP) and tolloid (TLL)-like 2 XM_134498 −1.33 0.050
Tekt1 Tektin 1 NM_011569.1 −1.33 0.002
Retnlg Resistin like gamma NM_181596.2 −1.32 0.047
Avil Advillin NM_009635.2 −1.32 0.003
Fgf10 Fibroblast growth factor 10 NM_008002.3 −1.31 0.036
Hist1h4b Histone 1, H4b NM_178193 −1.31 0.016
Jph2 Junctophilin 2 NM_021566.1 −1.30 0.042
Arhgap20 Rho Gtpase activating protein 20 NM_175535 −1.30 0.017
Fancl Fanconi anaemia, complementation group l NM_025923.2 −1.30 0.027
Cyhr1 Cysteine and histidine rich 1 NM_019396 −1.30 0.037
Tinag Tubulointerstitial nephritis antigen NM_012033.2 −1.30 0.017
Dguok Deoxyguanosine kinase AK003639 −1.29 0.005
Rora Rar-related orphan receptor alpha NM_013646.1 −1.29 0.018
Stat1 Signal transducer and activator of transcription 1 BC057690.1 −1.29 0.026
Csf-1 Colony stimulating factor 1 X05010 −1.28 0.047
Ubtf Upstream binding transcription factor, RNA polymerase i NM_011551 −1.28 0.020
Atxn7l2 Ataxin 7 like protein 2 NM_175183.2 −1.27 0.023
Arhgap20 Rho Gtpase activating protein 20 NM_175535 −1.27 0.038
Cd209a CD209a antigen NM_133238.2 −1.27 0.023
Aqp9 Aquaporin 9 NM_022026.2 −1.26 0.009
Dpysl3 Dihydropyrimidinase-like 3 NM_009468.1 −1.26 0.021
Enpp2 Ectonucleotide pyrophosphatase/phosphodiesterase 2 NM_015744 −1.26 0.000
Ache Acetylcholinesterase NM_009599.2 −1.26 0.016
Cul9 Cullin 9 NM_001081335 −1.26 0.039
Ube2d1 Ubiquitin-conjugating enzyme E2D 1, UBC4/5 homologue (yeast) NM_145420.1 −1.26 0.027
Astn2 Astrotactin 2, transcript variant 1 NM_207109.1 −1.26 0.049
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we used quantitative PCR to validate the differential
expression of mRNAs encoding Akt in skeletal muscle,
liver and adipose tissue of male sg/sg mice relative to wild-
type littermates (see Fig. 3a–l).
We observed significantly increased levels of Akt1 and
Akt2 (variant 2) mRNA, but not of Akt3 mRNA in muscle
from (fasted) sg/sg mice (Fig. 3a–d). Interestingly, two
variants of Akt2 have been described in the NCBI database
(ncbi.nlm.nih.gov/nucleotide, accessed 17 December 2010).
Variants 1 and 2 are produced by alternate promoter usage
and result in exon 1 encoding different 5′ untranslated
region sequences (Fig. 3m). Variant 2, but not variant 1,
mRNA was increased in staggerer mice (Fig. 3b, c).
Notably, no significant changes in Akt1, Akt2 (variants 1
and 2) or Akt3 mRNA expression were observed in liver or
adipose tissue (Fig. 3e–i).
Levels of Rorα mRNA in the muscle of heterozygous
staggerer mice are approximately half of those in wild-type
mice (ESM Fig. 1b). To understand further the effect of
Rorα expression on transcription of Akt isoforms, we
analysed the expression of Akt1, Akt2 variant 1 and Akt2
variant 2 mRNAs in the heterozygote (RORα haplo-
insufficient mice). The expression of Akt2 variant 2 (but
Fig. 3 Quantitative PCR of
Akt1, Akt2 (variant [var] 1 and
var 2) and Akt3 mRNA in (a–d)
quadriceps muscle, (e–h) liver
and (i–l) epididymal adipose
tissue of male sg/sg mice (black
columns) relative to wild-type
littermates (white columns).
n=7–8 per group, ***p<0.001
by t test. m Schematic repre-
sentation of genomic structure
of Akt2 var 1 and Akt2 var 2,
and use of alternative promoter.
Excerpt from MGI mouse ge-
nome browser at website as
cited [45]. n–p Quantitative
PCR of Akt1, Akt2 var1 and Ak2
var 2 mRNA in quadriceps
muscle of male wild-type (white
columns), heterozygous sg/+
(striped columns) and
homozygous sg/sg mice (black
columns) (3–7 months old).
n=10–12 per group, *p<0.05,
**p<0.01 and ***p<0.001 by
one-way ANOVA with
Bonferroni’s post hoc test. All
bar graph values mean±SEM,
with relative mRNA expression
normalised against 18S rRNA
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mice was intermediate between wild-type and homozygous
staggerer (sg/sg) mice (Fig. 3o, p). In contrast Akt1 mRNA
expression was similar to that of wild-type mice (Fig. 3n).
We also determined by western blot analysis whether
changes in mRNA expression correlated with changes in the
protein levels of total AKT (Fig. 4a) and phosphorylated
(serine amino acid residue 473 [ser473]) AKT (Fig. 4b)i n
quadriceps muscle of wild-type and sg/sg mice in the basal
(unstimulated) state. We observed a significant increase in
total AKT protein (normalised against glyceraldehyde-3-
phosphate dehydrogenase [GAPDH] protein) in the skeletal
muscle from sg/sg mice relative to wild-type littermate pairs
(Fig. 4a), corresponding with the mRNA expression data. In
addition, levels of the active phosphorylated (ser473) AKT
species was also significantly increased (normalised against
GAPDH) (Fig. 4b) in the basal condition.
Aberrant expression in sg/sg mice of genes involved in
regulation of glucose tolerance and metabolic disease The
nodes of the insulin signalling pathway (underscoring the
central role of AKT2) are summarised in Fig. 5a. We used
quantitative PCR to analyse mRNA expression of the p85α
(also known as Pik3r1) and p85β (also known as Pik3r2)
regulatory subunits of PI3K. However, no significant
differences in expression were observed in the muscle of
male sg/sg mice (Fig. 5b, c).
We also validated the differential expression of Tbc1d1
(which encodes a Rab GTPase-activating protein, and the
paralogue Tbc1d4 [also known as As160]) and several other
genes in the sg/sg mice (relative to wild-type littermates).
These genes have been implicated in AKT signalling and the
regulation of glucose tolerance and/or insulin sensitivity. For
example, TBC1D1 has recently been identified (as an AKT
substrate) in the insulin-stimulated AKT cascade that facili-
tates GLUT4 translocation [21] and regulates glucose uptake
[22]. The Tbc1d1 and Tbc1d4 mRNA were significantly
induced (about threefold) and decreased, respectively (Fig. 5d,
e)i nsg/sg mice. Serum- and glucocorticoid-inducible kinase 1
(Sgk1) was similarly induced by about threefold (Fig. 5f).
Serum- and glucocorticoid-inducible kinase 1 modulates salt-
dependent glucose uptake and mediates several PI3K
responses, with emerging evidence suggesting it interacts with
AKT kinases and mammalian transducer of regulated cAMP
response element-binding protein 2 [23]. Polymorphisms (and
increases) of paraoxonase 1 are associated with glucose
intolerance and type 2 diabetes, and, consistent with the
phenotype, was decreased by about twofold (Fig. 5g). Finally,
Tip47 (also known as Plin3) in skeletal muscle has been
shown to maintain insulin sensitivity [24–26]; its mRNA was
significantly induced by about 2.5-fold (Fig. 5h).
With regard to glucose transporters, we observed no
changes in expression of Glut1 (also known as Slc2a1)
mRNA (data not shown); however, we did observe a small
but significant increase in Glut4 (also known as Slc2a4)
mRNA expression (Fig. 5i). The increase in Glut4 mRNA
was reflected in a significant, approximately twofold increase
in the level of GLUT4 protein after western blot analysis of
sg/sg mice, relative to wild-type littermates (n=9; Fig. 5j).
The differential expression of these genes in muscle of
sg/sg mice was consistent with improved insulin sensitivity,
and with increased AKT levels and AKT phosphorylation.
These analyses thus revealed that several components of the
insulin signalling pathway are modulated in the sg/sg
phenotype, these modulations being associated with de-
creased blood glucose and improved insulin signalling.
Staggerer mice display significantly elevated 'absolute
levels' of pAKT and total AKT protein in the basal and
insulin-stimulated states, and have enhanced ex vivo
glucose uptake We subsequently examined whether sg/sg
mice display increased insulin-mediated AKT phosphory-
lation. Whole-cell extracts from quadriceps muscles were
Fig. 4 Western blot analyses of (a) AKT and (b) pAKT relative to
GAPDH in skeletal muscle (quadriceps) of male sg/sg and wild-type
(WT) littermate control mice, with densitometry analysis of western
blots; n=4 per group, mean±SEM; *p<0.05 and ***p<0.001 by t
test. c Western blot analyses (representative blot from two experi-
ments) of AKT and (d) pAKT relative to GAPDH in skeletal muscle
(quadriceps) of male wild-type (Wt) and sg/sg littermate mice treated
with saline and insulin (0.5 U/kg i.p. for 10 min). Densitometry was
analysed using both experiments; n=4–6 per group, mean±SEM; *p<
0.05 and **p<0.01 two-way ANOVA with Bonferroni’s post hoc test
1176 Diabetologia (2011) 54:1169–1180isolated from saline- and insulin-injected mice were
analysed by western blot analysis using antibodies specific
to AKT and pAKT. We observed significantly elevated
'absolute levels' of total AKT protein (in the basal and
insulin-stimulated states) in quadriceps muscle from sg/sg
mice (normalised against GAPDH) (Fig. 4c). We also
observed significantly elevated 'absolute levels' of insulin-
stimulated phosphorylation of AKT (ser473) in sg/sg mice
(normalised against GAPDH) (Fig. 4d).
We next investigated whether the improved insulin
sensitivity and elevated 'absolute' levels of AKT and pAKT
in sg/sg mice resulted in increased ex-vivo glucose uptake
in EDL muscle (type II fast twitch glycolytic muscle)
(Fig. 6). In keeping with the increase in AKT level and
phosphorylation, EDL muscle of sg/sg mice showed
significantly higher rates of 2-deoxy-D-glucose uptake than
wild-type mice in the basal and insulin-stimulated state.
Discussion
A recent review [8] underscored the diverse roles of RORs
in development, immunity, circadian rhythm, lipid homeo-
stasis and metabolism. Moreover, (dysfunctional) levels of
this NR are associated with ataxia, autoimmune disease,
dyslipidaemia, atherosclerosis and resistance to diet-
induced obesity. The sg/sg mice are Rorα-deficient, sg/sg
is a non-functional null allele and sg/sg mice do not express
functional RORα [12]. Moreover, sg/sg mice display
identical phenotypes to the Rorα-knockout mice, which
do not produce RORα protein [12, 27].
The pathophysiological phenotypes in sg/sg mice are
consistent with changes in the expression of genes such as
Srebp-1c (also known as Srebf1), Apoa1, Apoc3 and IκBα
(also known as Nfkbia)[ 4, 7, 9, 28]. We have previously
shown that sg/sg mice have significantly reduced Rorα1
and Rorα4 expression [9], and display increased expression
of Lipin 1 and Pgc-1α (also known as Ppargc1a), and
Fig. 6 2-Deoxy-D-[
3H]glucose uptake assays of control and insulin-
treated EDL muscle explants from male wild-type (Wt) and sg/sg mice
(3–7 months old); n=7–10 per group, mean±SEM; *p<0.05 and
**p<0.01 By two-way ANOVA with Bonferroni’s post hoc test
Fig. 5 a Schematic representa-
tion of the insulin-mediated
glucose disposal pathway in
skeletal muscle. InsR, insulin
receptor. b–i Quantitative PCR
of mRNA from skeletal muscle
(quadriceps) of male sg/sg
(black columns) mice relative to
wild-type (Wt) littermates
(white columns) for genes as
labelled. Relative mRNA ex-
pression was normalised against
18S rRNA; n=7–8 per group,
mean±SEM; *p<0.05, **p<
0.01 and ***p<0.001, by t test.
j Western blot analyses of
GLUT4 in skeletal muscle
(quadriceps) from male sg/sg
and wild-type (WT) littermate
control mice, with densitometry
analysis (grey, sg/sg; white,
wild-type littermate control) us-
ing both western blots; n=8–9
per group, mean±SEM; *p<
0.05 by t test
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sion of these genes is consistent with the ability of sg/sg
mice to resist diet-induced obesity and hepatic triacylgly-
cerol accumulation [9].
To date, the role of RORα in the control of insulin
sensitivity and glucose uptake remains obscure. The links
and interactions between fatty acid and carbohydrate
homeostasis in whole-body physiology, and in the patho-
physiological development of glucose intolerance and
insulin resistance underscore the need to examine the role
of this NR in carbohydrate metabolism. Consequently, we
examined the outcomes of aberrant RORα function in
muscle, a tissue that accounts for the bulk of insulin-
stimulated glucose disposal [29]. The (male) sg/sg mice
present with significantly reduced fasting serum glucose
and improved insulin sensitivity relative to wild-type
littermates. Our results differ from those of Kang et al.
who showed a lack of serum glucose phenotype in sg/sg
compared with their wild-type mice [30]. The nature of this
difference is still not known. Recently it has been suggested
that, in mice, a 6 h fast provides a more physiologically
relevant baseline, increased sensitivity and fewer confound-
ing variables for the evaluation of serum glucose and
glucose tolerance [31, 32].
Expression profiling identified differential regulation of
genes in the skeletal muscle of sg/sg mice. Similarly, bi-
directional changes in gene expression have been observed
in liver of sg/sg mice [30]. In the analysis reported here, the
upregulated subset of genes was associated with cardiovas-
cular and metabolic disease, cell death, infection, immunity
and inflammation. This is consistent with the defined role
of RORα in atherosclerosis, lipid homeostasis, fat deposi-
tion, obesity and inflammation [8, 33]. Interestingly, the
primary signalling pathway upregulated in muscle was the
PI3K–AKT pathway, a central control point for insulin-
stimulated glucose uptake. Two RNA variants of Akt2 have
been identified. We showed that Akt2 variant 2 was highly
expressed in epididymal fat and (quadricep) skeletal
muscle, but not in liver of wild-type mice. We observed
significant differential expression of Akt1 and Akt2 variant
2 in quadriceps of sg/sg mice, indicating a specific role for
these signalling molecules in skeletal muscle.
Interestingly, we had previously demonstrated that trans-
genic muscle-specific overexpression of dominant-negative
RORα1 leads to decreased Akt2 mRNA expression, glucose
intolerance, decreased insulin-stimulated phosphorylation of
AKTand glucose uptake [17]. In this study, we observed that
decreased (and dysfunctional) expression of Rorα (1 and 4)
led to increased Akt2 mRNA expression and improved
insulin sensitivity, and increased levels of basal and insulin-
stimulated phosphorylation of AKT and of glucose uptake.
Notably in this context, the staggerer strain has a
deletion of the fifth exon encoding the ligand binding
domain. The resulting frame shift encodes 'non-sense RNA'
and introduces a premature stop codon. However, further
analysis by northern blot [34] and RT-PCR [9] revealed
greater than tenfold decreases in Rorα1 and Rorα4 mRNA
expression. Moreover, northern blot analysis [12] was not
able to detect the transcript in homozygous sg/sg mice.
Gold et al. [34] state that this is consistent with ‘degrada-
tion of the mutant mRNA through the non-sense mediated
decay pathway’. In agreement with this, sg/sg mice do not
produce the RORα protein. Although initially thought to
have a dominant-negative form of RORα, sg/sg mice are in
fact Rorα-deficient. In contrast to this, our previous study
[17] used a construct that abundantly/ectopically expresses
a stable truncated Rorα mRNA transcript with an in-frame
stop codon. The truncated Rorα ΔDE includes the encoded
amino acids 1–235 [17], but lacks the ligand binding
domain and part of the hinge region. McBroom et al. [35]
and Lau et al. [2] reported that deletion of this segment
preserved DNA recognition and binding, suppressed trans-
activation and operated in a dominant-negative manner. In
addition, Hamilton et al. [11] reported that the staggerer
mutation is located in a similar position and produces a
non-functional ligand binding domain.
This apparent paradox in ROR function has a precedence
in the NR field and there are a number of factors to consider.
In the first instance, our previous transgenic mouse model
overexpressed a dominant-negative Rorα1 transcript, spe-
cifically in skeletal muscle [17]. In comparison, the present
study investigated sg/sg mice, which lack Rorα1 and
Rorα4 expression in all tissues. Second, in mice lacking
NR, ‘bona fide’ target genes are often derepressed, resulting
in paradoxically increased expression [36]. We suggest the
data are consistent with decreased (and dysfunctional)
RORα expression leading to derepression and increase of
Akt2 mRNA expression. This is consistent with our
observation that RORα is selectively recruited to the Akt2
promoter and that dominant-negative overexpression
represses Akt2 mRNA expression [17]. More importantly,
these studies clearly identify a link between Rorα expres-
sion, Akt2 and glucose tolerance.
Previous studies [37, 38] have demonstrated transcrip-
tional regulation of Rev-erbα (also known as Nr1d1)b y
RORα and decreased Rev-erbα mRNA expression in sg/sg
mice [37]. However, this did not explain the increased
expression of Akt2 mRNA in the sg/sg mice. For example,
we also observe decreased expression of Rev-erbα in sg/sg
mice; however, there was no decrease in REV-ERBα
protein (ESM Fig. 6). This is consistent with another report
[39], which showed ‘dissociation between mRNA and
protein levels’.
In the context of improved insulin sensitivity, glucose
uptake and increased AKT levels, we also observed
increased Tbc1d1 and Glut4 expression. This is entirely
1178 Diabetologia (2011) 54:1169–1180consistent with Peck and colleagues [21], who very recently
showed that activated AKT phosphorylates TBC1 domain
family, member 1 (TBC1D1) and enhances glucose uptake.
We also used quantitative PCR to validate the differential
expression of several other mRNAs, including Pon1 and
Sgk1, that are associated with type 2 diabetes, insulin
secretion and metabolic syndrome [40, 41]a n da l s o
appeared in several categories, similarly to Akt2.
We were particularly interested in AKT2, as this protein
is an integral component of the signalling pathway
controlling insulin signalling. For example, several inves-
tigations have reported that AKT2 is a major regulator of
insulin-mediated glucose disposal in skeletal muscle.
Aberrant Akt2 gene expression in rodents is associated
with insulin resistance, type 2 diabetes-like syndrome, age-
dependent lipodystrophy [42, 43] and phosphorylation of
TBC1D1.
The threefold increase in expression of Tbc1d1 mRNA,
initially appears paradoxical. Mutations in Tbc1d1 are
associated with morbid obesity, for example, the R125W
mutation in humans. However, the functional outcomes of
these mutations have not yet been characterised. In the
context of improved insulin sensitivity, glucose uptake and
increased AKT level (and phosphorylation), we also
observed increased Tbc1d1 and Glut4 expression. These
observations are consistent with the latest studies on
Tbc1d1 function. Peck and colleagues recently demonstrat-
ed that AKT phosphorylation of TBC1D1 (similar to AKT
substrate, 160 kDa/TBC1 domain family, member 4)
enables GLUT4 translocation [21]. Second, the obesity-
related mutant R125W Tbc1d1 decreases insulin-stimulated
glucose transport [22]. Both groups suggest that impaired
glucose uptake provides a potential mechanism for the
associated obesity. The differential (and increased) produc-
tion of this Rab GTPase-activating protein, coupled to
increased pAKT level in sg/sg mice, is interesting from the
perspective of a potential contribution to resistance to diet-
induced obesity in sg/sg mice via increased glucose uptake.
Interestingly, and consistent with increased insulin
sensitivity, sg/sg mice showed enhanced insulin-mediated
AKT phosphorylation and glucose uptake (and increased
GLUT4 protein levels) in skeletal muscle. Recently, Duez
et al. [44] showed that overexpression of Rorα4 in 3T3-L1
cells inhibits pre-adipocyte differentiation, Glut4 transcrip-
tion and insulin-induced glucose uptake. In agreement with
this, we have shown here that the GLUT4 protein level was
increased in muscle from sg/sg mice.
In conclusion, the NR, RORα, is involved in regulation
of AKT production and signalling, and glucose uptake.
This study extends previous evidence that RORα performs
a critical role in the regulation of adiposity. Further studies
are required to examine whether this NR can be therapeu-
tically exploited.
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